Human synonyms | FAR1 | MLSTD2|PFCRD|SDR10E1 | GeneID:84188 | ENSG00000197601 | Q8WVX9 |
Mouse ortholog | Far1 | 2600011M19Rik|2900034E22Rik|3732409C05Rik|AI850429|Mlst|Mlstd2 | GeneID:67420 | ENSMUSG00000030759 | Q922J9 |
Tissue Atlas Coexpression | human GTEx RNA, mouse GNFv3 RNA, mouse protein |
CCLE cell lines | CRISPR-codependency, RNA-seq coexpression, RNA-microarray, CRISPR-vs-RNA-seq |
Sequence Alignment (MitoCarta only) | all_BBH, selected_BBH |
In MitoCarta3.0? | 0 |
Evidence | mito protein domain |
MitoPathway | |
Sub-Mito Localization | |
MS/MS tissues | |
MitoCarta2.0 FDR | 0.767 |
MitoCarta2.0 Training | Tnon_mito |
TargetP_v1 MTS Confidence | |
MitoDomain | SharedDomain |
Yeast Homolog | NoMitoHomolog |
Rickettsia Homolog | NoHomolog |
GeneAtlas Coexpression N50  | 1 |
PGC Induction | |
MSMS score | |
MSMS intensity | cerebrum:, cerebellum:, brainstem:, spinalcord:, kidney:, liver:, heart:, muscle:, adipose:, sm_intestine:, lg_intestine:, stomach:, placenta:, testis: |
MSMS unique peps | |
Curator notes |
HPA Main Location (2020) | Peroxisomes (Supported) |
PFAM domains (2022) | NAD_binding_4|Sterile |
CRISPR guides |
Glu/Gal Death Screen (2016) | not strongly enriched in Gal/Glu dead cells (fdr=1) |
O2 Screen Summary (2020) | Selectively essential in 21% vs 1% oxygen (fdr=0.0002) |
1%O2_vs_21%O2.day15.score (2020) | -3.7 |
21%O2.day15_vs_day0.score (2020) | 0.3 |
Chemical Genetics Zscore (To 2019) | |
TMRM Oligo Zscore (unpublished) | -1.6 |
Species | mRNA | ProteinID | Len (AA) | TargetP v1.0 | TargetP v2.0 | TPpred2 | MitoFates | Mouse Best | TMHMM # Helices | TMHMM Topology |
---|---|---|---|---|---|---|---|---|---|---|
mouse | NM_001285831 | NP_001272760 | 515 | no pred (conf=2) | noTP | noMTS (score=1) | 1 | o466-483i | ||
mouse | NM_027379 | NP_081655 | 515 | no pred (conf=2) | noTP | noMTS (score=1) | 1 | o466-483i | ||
human | NM_032228 | NP_115604 | 515 | no pred (conf=2) | noTP | noMTS (score=1) | 1 | o466-483i |